The Missouri Technology Corp. and a host of other investors will receive a payout that could reach $100 million.
MTC, which is a state-run investment entity that invests in tech and bioscience-focused startups, invested roughly $400,000 in Confluence Life Sciences, a St. Louis startup that is developing new drugs to treat cancer and other inflammatory diseases. MTC matches outside venture capital and has seen its funding significantly cut by state lawmakers.
According to the St. Louis Business…
The Missouri Technology Corp. and a host of other investors will receive a payout that could reach $100 million.
MTC, which is a state-run investment entity that invests in tech and bioscience-focused startups, invested roughly $400,000 in Confluence Life Sciences, a St. Louis startup that is developing new drugs to treat cancer and other inflammatory diseases. MTC matches outside venture capital and has seen its funding significantly cut by state lawmakers.
According to the St. Louis Business…